Relapse for patients with primary smear-positive pulmonary tuberculosis and pyrazinamide-resistance
10.3969/j.issn.1006-5725.2016.13.044
- VernacularTitle:吡嗪酰胺耐药对初治菌阳肺结核复发的影响
- Author:
Shengjing HUANG
;
Yunwei RAO
;
Shouyong TAN
- Publication Type:Journal Article
- Keywords:
Tuberculosis,pulmonary;
Pyrazinamide;
Drug resistance;
Therapeutic effect;
Relapse
- From:
The Journal of Practical Medicine
2016;32(13):2224-2226
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the relapse rate of the patients with primary smear-positive pulmonary tu-berculosis and pyrazinamide-resistance. Methods Retrospective analysis was made on the relapse for 150 patients with primary smear-positive pulmonary tuberculosis , who had been diagnosed and completed treatment in Guangzhou Chest Hospital from January 2012 to August 2013 , and had followed up two years. According to the re-sults of drug susceptibility test before treatment, they were divided into pyrazinamide-sensitive (114 cases) and pyrazinamide-resistant (36 cases) groups. Results (1)By the end of the treatment, the recovery rates in the sensi-tive group and resistant group were 98.25%and 88.89%respectively (P=0.044). The rate of the lesions absorption was 99.12%and 94.44%respectively (P=0.143). The rate of the cavity shrinking was 89.01% and 70.37% re-spectively (P = 0.039). The rate of the relapse was 3.57% and 6.25% respectively (P = 0.867) within 2 years fol-low-up in the sensitive group and the resistant group. Conclusions PZA has certain effects on the patients with primary smear-positive pulmonary tuberculosis. Those who are tolerant would have lower incidence for cavity shrink-ing. But the relapse rate for two-year follow-up showed there were not significant differences in two groups.
